Induction of mania with serotonin reuptake inhibitors

Journal of Clinical Psychopharmacology

Volumn 16, Issue 6, 1996, Pages 425-427

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; MALE; MANIA; PRIORITY JOURNAL;

ADULT; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS;

EID: 0030446232     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199612000-00003     Document Type: Article

References (21)

1. Zornberg GL, Pope HG. Treatment of depression in bipolar disorder new directions for research. J Clin Psychopharmacol 1993; 13:397-408.
2. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144:1403-11.
3. Himmelhoch JM, Thase ME, Mallinger AG, Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991;148:910-6.
4. Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JF. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994;55:391-3.
5. Terao T. Comparison of manic switch onset during fluoxetine and trazodone treatment. Biol Psychiatry 1993;33:477-8.
6. Stoll AL, Mayer PV, Kolbrener M, Goldstein E, Suplit B, Lucier J, Cohen BM, Tohen M. Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry 1994;151:1642-5.
7. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164:549-50.
8. Benfield P, Heel RC, Lewis SP. Fluoxetine. Drugs 1986;32: 481-508.
9. Cohn JB, Collins G, Ashbrook E, Wemicke JF. A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989;4:313-22.
10. Simpson SG, DePaulo JR. Fluoxetine treatment of bipolar II depression. J Clin Psychopharmacol 1991;11:52-4.
11. Quitkin FM, McGrath P, Liebowitz MR, Stewart J, Howard A. Monoamine oxidase inhibitors in bipolar endogenous depressives. J Clin Psychopharmacol 1981;1:70-4.
12. Saletu B, Schjerve M, Grunberger J, Schanda H, Arnold OH. Fluvoxamine - a new serotonin re-uptake inhibitor: first clinical and psychometric experiences in depressed patients. J Neural Transm 1977;41:17-36.
13. Montejo-Iglesias ML, Ramos-Brieva JA. Therapeutic effect of maprotiline and chlorimipramine: controlled study. Neuropsychobiology 1988;19:20-4.
14. Murphy DL, Baker M, Goodwin FK, Miller H, Kotin J, Bunney WE. L-Tryptophan in affective disorders: indoleamine changes and differential clinical effects. Psychopharmacologia 1974;34: 11-20.
15. Farkas T, Dunner DL, Fieve RR. L-Tryptophan in depression. Biol Psychiatry 1976;11:295-302.
16. Chouinard G, Young SN, Bradwejn J, Annable L. Tryptophan in the treatment of depression and mania. Adv Biol Psychiatry 1983;10:47-66.
17. Heun R, Maier W. The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: results of a controlled family study. Acta Psychiatr Scand 1993;87:279-84.
18. Dunner DL. A review of the diagnostic status of "bipolar II" for the DSM-IV work group on mood disorders. Depression 1993;1:2-10.
19. Kupfer DJ, Carpenter LL, Frank E. Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatry 1988;145:804-8.
20. Howland RH, Thase ME. A comprehensive review of cyclothymic disorder. J Nerv Ment Dis 1993;181:485-93.
21. Howland RH. Health status, health care utilization, and medical comorbidity in dysthymia. Int J Psychiatry Med 1993;23:211-38.